Rhabdomyolysis — Diagnosis and Management

Key Points

• CK elevation in a compatible clinical setting is the practical basis of diagnosis; the classic symptom triad is uncommon.
• Hyperkalemia is the most urgent early electrolyte threat and requires immediate treatment when severe.
• Isotonic crystalloid is the cornerstone of AKI prevention, but fluid should be goal directed to avoid volume overload.
• Either lactated Ringer solution or saline is acceptable for initial volume therapy according to the AAST consensus.
• Common urine-output goals are approximately 1 to 3 mL/kg per hour, up to about 300 mL per hour.
• Routine bicarbonate, mannitol, and diuretics are not recommended solely to prevent rhabdomyolysis-associated AKI.
• Renal replacement therapy is used for standard AKI indications, not prophylactically to clear myoglobin.
• Always look for compartment syndrome and ongoing causes such as heat stroke, seizure, ischemia, toxins, or drug interactions.

Algorithm

1. Identify the inciting event and examine for muscle injury, limb ischemia, and compartment syndrome.
2. Obtain CK, potassium, creatinine, bicarbonate, calcium, phosphate, magnesium, urinalysis, and ECG when electrolyte risk is significant.
3. Stop causative drugs or toxins and treat seizure, hyperthermia, ischemia, infection, or other ongoing injury.
4. Treat life-threatening hyperkalemia immediately using standard emergency therapy.
5. Begin isotonic crystalloid when there is volume depletion or meaningful risk of pigment-associated AKI.
6. Titrate fluids to perfusion and urine output rather than using a fixed volume; avoid fluid creep.
7. Trend CK, renal function, potassium, phosphate, calcium, and volume status.
8. Do not add bicarbonate or mannitol routinely for AKI prevention.
9. If urine output remains poor despite adequate perfusion, reassess for established AKI and avoid endless fluid escalation.
10. Use dialysis for conventional indications such as refractory hyperkalemia, severe acidosis, uremic complications, or volume overload.

Clinical Synopsis & Reasoning

Rhabdomyolysis results from skeletal-muscle injury severe enough to release intracellular contents into the circulation. Causes include crush injury, prolonged immobilization, seizures, extreme exertion, heat stroke, limb ischemia, compartment syndrome, infection, metabolic disorders, alcohol, stimulants, toxins, and medications such as statins, particularly when interacting drugs or severe systemic illness are present. The classic triad of muscle pain, weakness, and dark urine is uncommon, so diagnosis requires attention to the exposure and laboratory findings rather than waiting for all three features.

Creatine kinase is the standard practical marker. Definitions vary, but CK greater than five times the upper limit of normal or above approximately 1000 U/L is commonly used to identify rhabdomyolysis in the appropriate clinical setting. CK usually rises over several hours and may peak one to three days after injury. Urine dipstick can be positive for blood from myoglobin despite few or no red cells on microscopy, but myoglobin is cleared rapidly and a negative urine test does not exclude the diagnosis. The risk of acute kidney injury depends on more than CK alone and is influenced by hypovolemia, acid-base status, baseline kidney function, sepsis, electrolyte derangement, and overall illness severity.

The most immediately dangerous electrolyte abnormality is hyperkalemia, which can cause fatal dysrhythmia early in the course. Hyperphosphatemia and hypocalcemia also occur as injured muscle releases phosphate and calcium shifts into damaged tissue. Early hypocalcemia is usually not treated unless it is symptomatic or treatment is required in the setting of dangerous hyperkalemia, because calcium may later rebound during recovery. Compartment syndrome must be considered whenever there is severe focal pain, tense swelling, neurologic deficit, or ischemic concern. Acute kidney injury develops through hypovolemia, renal vasoconstriction, tubular oxidative injury, and myoglobin-associated tubular obstruction.

Treatment Strategy & Disposition

Stop the muscle injury when possible and treat the precipitating cause. Restore renal perfusion with isotonic crystalloid in patients who are volume depleted or at meaningful risk for pigment-associated AKI. The American Association for the Surgery of Trauma consensus considers either lactated Ringer solution or saline acceptable. A starting infusion around 400 mL per hour can be reasonable in a substantially affected adult, with a broad range of approximately 200 to 1000 mL per hour depending on size, losses, comorbidity, and severity. Fluids must be titrated rather than given blindly because excessive administration can cause life-threatening volume overload.

Urine output is a useful resuscitation endpoint. Common targets are approximately 1 to 3 mL/kg per hour, up to about 300 mL per hour. If the patient remains oliguric or anuric despite adequate resuscitation, escalating fluid indefinitely is harmful. Reassess for established AKI, obstruction, shock, or compartment syndrome and use standard indications for renal replacement therapy. Dialysis is not recommended prophylactically simply to remove myoglobin or prevent AKI.

Routine sodium bicarbonate infusion or mannitol is not recommended for prevention of rhabdomyolysis-associated AKI because clinical evidence has not shown consistent benefit beyond good volume resuscitation. Bicarbonate still has conventional indications, such as selected severe metabolic acidosis or as part of hyperkalemia treatment in appropriate circumstances, but that is different from routine urine alkalinization. Treat dangerous hyperkalemia immediately with standard membrane stabilization and intracellular-shift therapy. Correct hypoglycemia and clinically significant magnesium or sodium disorders. Fasciotomy is required for confirmed compartment syndrome. Admit patients with substantial CK elevation plus AKI, significant electrolyte abnormalities, ongoing muscle injury, systemic illness, inability to maintain oral hydration, or an uncertain trajectory. Patients with mild disease, normal renal function and electrolytes, a controlled cause, and reliable follow-up may be managed without prolonged hospitalization in selected cases.

Epidemiology / Risk Factors

• Trauma, prolonged immobilization, seizures, substance use, exertion, and heat illness are common emergency causes.
• Drug-associated cases include statins, antipsychotics in neuroleptic malignant syndrome, stimulants, and multiple toxic exposures.
• Crush injury can produce abrupt hyperkalemia and shock when trapped muscle is reperfused.
• Severe exertional rhabdomyolysis occurs in athletes, military trainees, and unacclimatized individuals, particularly with heat stress or sickle cell trait in selected contexts.
• AKI risk increases with greater systemic illness, dehydration, sepsis, acidosis, and preexisting kidney disease.
• Recurrent unexplained rhabdomyolysis may indicate a metabolic, genetic, endocrine, or inflammatory muscle disorder.

Investigations

Complications and Management

Pharmacology

Prognosis / Complications

• Most patients recover fully when the inciting injury stops and renal perfusion and electrolytes are managed early.
• Severe AKI, refractory hyperkalemia, compartment syndrome, sepsis, and multiorgan failure increase mortality.
• CK magnitude correlates imperfectly with outcome and should not be used as the sole discharge or dialysis criterion.
• Renal function often recovers even after temporary dialysis when the underlying muscle injury resolves.
• Persistent weakness after CK normalization suggests an underlying myopathy or ongoing muscle disease that requires further evaluation.
• Recurrence is preventable when medication interactions, heat risk, exertional triggers, or substance exposure can be modified.

Patient Education / Counseling

• Explain the cause when known and advise avoidance of the triggering drug, substance, or exertional pattern until medically reassessed.
• After exertional rhabdomyolysis, return to intense exercise should be gradual and delayed until symptoms, CK, and renal function have recovered.
• Teach patients taking statins to report severe new muscle pain, weakness, or dark urine, especially after a medication change.
• Maintain appropriate hydration during heat and endurance activity without forced excessive water intake.
• Seek urgent care for weakness, dark urine, reduced urine output, palpitations, severe swelling, or recurrent muscle pain.
• Patients with unexplained recurrent episodes may need neuromuscular or metabolic evaluation rather than repeated treatment alone.

Notes

The major correction to older rhabdomyolysis protocols is that alkaline diuresis and mannitol should not be automatic. The AAST clinical consensus found insufficient evidence that sodium bicarbonate or diuretics prevent AKI and recommends against their routine use for that purpose. Early, appropriately titrated isotonic crystalloid remains the main preventive intervention.

Fluid therapy must have an endpoint. Common urine-output targets are 1 to 3 mL/kg per hour, but persistent anuria despite adequate perfusion should trigger reassessment rather than endless fluid administration. Continuing large-volume crystalloid in an anuric patient can convert renal failure into severe pulmonary edema.

The bedside priorities are dangerous potassium elevation, the cause of muscle injury, renal trajectory, and compartment syndrome. CK is useful for diagnosis and trend but should not dominate decision-making in isolation.

References

1. AAST Critical Care Committee Clinical Consensus Document on Rhabdomyolysis — Link